Literature DB >> 11052843

Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries.

S W Park1, C W Lee, M K Hong, J J Kim, G Y Cho, D Y Nah, S J Park.   

Abstract

AIMS: Angioplasty of lesions in small coronary arteries remains a significant problem because of the increased risk of restenosis. The aim of this study was to compare the efficacy of elective coronary stent placement and optimal balloon angioplasty in small vessel disease.
METHODS: One hundred and twenty patients with lesions in small coronary arteries (de novo, non-ostial lesion and reference diameter <3 mm) were randomly assigned to either balloon angioplasty or elective stent placement (7-cell NIR stent). The primary end-point was restenosis at 6 months follow-up. Optimal balloon angioplasty was defined as diameter stenosis less than or = 30% and the absence of major dissection after the angioplasty, and crossover to stenting was allowed.
RESULTS: Baseline clinical and angiographic characteristics were similar in the two groups. Procedure was successful in all patients, and in-hospital events did not occur in any patient. However, 12 patients in the angioplasty group were stented because of suboptimal results or major dissection. Postprocedural lumen diameter was significantly larger in the stent group than in the angioplasty group (2.44 +/- 0.36 mm vs 2.14 +/- 0.36, P<0.05, respectively), but late loss was greater in the stent group (1.12 +/- 0.67 mm vs 0.63 +/- 0.48, P<0.01, respectively). The angiographic restenosis rate was 30.9% in the angioplasty group, and 35.7% in the stent group (P = ns). Clinical follow-up was available in all patients (15.9 +/- 5.7 months) and clinical events during the follow-up were similar in both groups.
CONCLUSIONS: These results suggest that optimal balloon angioplasty with provisional stenting may be a reasonable approach for treatment of lesions in small coronary arteries.

Entities:  

Mesh:

Year:  2000        PMID: 11052843     DOI: 10.1053/euhj.1999.1947

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Intracoronary stenting: developments since the NICE report.

Authors:  A H Gershlick
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Treatment of small coronary arteries with a paclitaxel-coated balloon catheter.

Authors:  Martin Unverdorben; Franz X Kleber; Hubertus Heuer; Hans-Reiner Figulla; Christian Vallbracht; Matthias Leschke; Bodo Cremers; Stefan Hardt; Michael Buerke; Hanns Ackermann; Michael Boxberger; Ralf Degenhardt; Bruno Scheller
Journal:  Clin Res Cardiol       Date:  2010-01-06       Impact factor: 5.460

3.  Zotarolimus-eluting stent utilization in small-vessel coronary artery disease (ZEUS).

Authors:  Man-Hong Jim; Kai-Hang Yiu; Raymond Chi-Yan Fung; Hee-Hwa Ho; Andrew Kei-Yan Ng; Chung-Wah Siu; Wing-Hing Chow
Journal:  Heart Vessels       Date:  2013-02-24       Impact factor: 2.037

4.  A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease.

Authors:  Atsushi Funatsu; Shigeru Nakamura; Naoto Inoue; Shinsuke Nanto; Masato Nakamura; Masashi Iwabuchi; Kenji Ando; Ryuta Asano; Seiji Habara; Shigeru Saito; Ken Kozuma; Kazuaki Mitsudo
Journal:  Clin Res Cardiol       Date:  2017-06-06       Impact factor: 5.460

Review 5.  Small coronary vessel angioplasty: outcomes and technical considerations.

Authors:  Sudhir Rathore
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

6.  The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study.

Authors:  Muhammad Dzafir Ismail; Wan Azman Wan Ahmad; Matthias Leschke; Matthias Waliszewski; Michael Boxberger; Imran Zainal Abidin; Ahmad Syadi Mahmood Zuhdi
Journal:  Springerplus       Date:  2016-09-27

Review 7.  Update on stents: recent studies on the TAXUS stent system in small vessels.

Authors:  Shuzou Tanimoto; Joost Daemen; Patrick W Serruys
Journal:  Vasc Health Risk Manag       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.